Table 3.

Logistic regression model for primary neutrophil engraftment in evaluable patients surviving at least 21 days (n = 6518)

FactorPrimary neutrophil engraftment
Odds ratio95% CIPFavorable
Donor age (per decade) 1.04 0.92-1.18 .53 NS 
Donor CMV positive (CMV-negative recipient)3-150 0.75 0.56-1.02 .07 NS  
Donor CMV positive (CMV-positive recipient)3-151 0.98 0.72-1.34 .91 NS  
Male donor 1.00 — — —  
Female donor (no pregnancies) 0.86 0.65-1.14 .30 NS  
Female donor (1 pregnancy) 1.09 0.69-1.74 .70 NS  
Female donor (≥2 pregnancies) 0.99 0.75-1.31 .95 NS  
ABO match 1.00 — — —  
ABO minor mismatch 1.12 0.86-1.48 .40 NS  
ABO major mismatch 0.95 0.74-1.21 .68 NS  
Donor race mismatch (white recipient) 0.90 0.67-1.20 .47 NS  
Donor race mismatch (minority recipient) 1.03 0.59-1.77 .93 NS 
HLA-A, -B, DRB1 match3-152 1.00 — — Matched 
HLA-A mismatch3-150 0.58 0.42-0.80 .0008 — 
HLA-B mismatch 0.52 0.37-0.73 .0002 —  
HLA-DRB1 mismatch 0.52 0.38-0.72 <.0001 — 
FactorPrimary neutrophil engraftment
Odds ratio95% CIPFavorable
Donor age (per decade) 1.04 0.92-1.18 .53 NS 
Donor CMV positive (CMV-negative recipient)3-150 0.75 0.56-1.02 .07 NS  
Donor CMV positive (CMV-positive recipient)3-151 0.98 0.72-1.34 .91 NS  
Male donor 1.00 — — —  
Female donor (no pregnancies) 0.86 0.65-1.14 .30 NS  
Female donor (1 pregnancy) 1.09 0.69-1.74 .70 NS  
Female donor (≥2 pregnancies) 0.99 0.75-1.31 .95 NS  
ABO match 1.00 — — —  
ABO minor mismatch 1.12 0.86-1.48 .40 NS  
ABO major mismatch 0.95 0.74-1.21 .68 NS  
Donor race mismatch (white recipient) 0.90 0.67-1.20 .47 NS  
Donor race mismatch (minority recipient) 1.03 0.59-1.77 .93 NS 
HLA-A, -B, DRB1 match3-152 1.00 — — Matched 
HLA-A mismatch3-150 0.58 0.42-0.80 .0008 — 
HLA-B mismatch 0.52 0.37-0.73 .0002 —  
HLA-DRB1 mismatch 0.52 0.38-0.72 <.0001 — 

The model also adjusted for disease, transplant center, cell dose, T-cell depletion, recipient CMV status, and race (results not shown). An odds ratio greater than 1.00 indicates a favorable outcome for engraftment.

CI indicates confidence interval; CMV, cytomegalovirus; and NS, not significant.

F3-150

Comparing CMV-seropositive donor with seronegative donor among seronegative recipients.

F3-151

Comparing CMV-seropositive donor with seronegative donor among seropositive recipients.

F3-152

Includes potential matches.

Close Modal

or Create an Account

Close Modal
Close Modal